<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cycloserin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Cycloserin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Cycloserin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Cycloserin_files/filelist.xml">
<title>CYCLOSERIN</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>4</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-07-30T16:15:00Z</o:Created>
  <o:LastSaved>2006-08-09T05:22:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>995</o:Words>
  <o:Characters>5675</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>47</o:Lines>
  <o:Paragraphs>13</o:Paragraphs>
  <o:CharactersWithSpaces>6657</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span lang=DE
style='font-size:9.0pt;mso-bidi-font-size:10.0pt;line-height:150%;font-family:
Verdana;mso-ansi-language:DE'>CYCLOSERIN<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Tên chung qu&#7889;c t&#7871;:</span></b><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'> Cycloserine.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='font-family:Verdana'>Mã ATC</span></b><span style='font-family:Verdana'>:
J04A B01.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='font-family:Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span
style='font-family:Verdana'> Kháng sinh.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></h2>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana;font-weight:normal'>Nang 250 mg.<o:p></o:p></span></h2>

<p class=cach0 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Cycloserin là kháng sinh tách ra t&#7915; <i>Streptomyces
orchidaceus </i>ho&#7863;c <i>Streptomyces garyphalus </i>và c&#361;ng
&#273;&#432;&#7907;c s&#7843;n xu&#7845;t b&#7857;ng ph&#432;&#417;ng pháp t&#7893;ng
h&#7907;p hóa h&#7885;c. Thu&#7889;c có c&#7845;u trúc gi&#7889;ng acid amin D
- alanin, vì th&#7871; cycloserin &#7913;c ch&#7871; các ph&#7843;n &#7913;ng
trong &#273;ó D - alanin tham gia t&#7893;ng h&#7907;p v&#7887; t&#7871; bào vi
khu&#7849;n. Trong môi tr&#432;&#7901;ng không có D - alanin, cycloserin &#7913;c
ch&#7871; s&#7921; phát tri&#7875;n các ch&#7911;ng <i>Enterococcus</i>, <i>Escherichia
coli</i>, <i>Staphylococcus aureus, Nocardia</i>, và <i>Chlamydia</i> in vitro.
Cycloserin có tác d&#7909;ng kìm khu&#7849;n hay di&#7879;t khu&#7849;n tùy
theo n&#7891;ng &#273;&#7897; c&#7911;a thu&#7889;c t&#7841;i v&#7883; trí t&#7893;n
th&#432;&#417;ng và tính nh&#7841;y c&#7843;m c&#7911;a vi khu&#7849;n gây b&#7879;nh.
&#7903; n&#7891;ng &#273;&#7897; 5 &#273;&#7871;n 30 microgam/ml cycloserin &#7913;c
ch&#7871; s&#7921; phát tri&#7875;n <i>Mycobacterium tuberculosis </i>in vitro.
Không có s&#7921; kháng chéo gi&#7919;a cycloserin v&#7899;i các thu&#7889;c ch&#7919;a
lao khác. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#432;&#7901;i ta &#273;ã th&#7845;y có hi&#7879;n
t&#432;&#7907;ng kháng thu&#7889;c t&#7921; nhiên và m&#7855;c ph&#7843;i
&#273;&#7889;i v&#7899;i cycloserin c&#7911;a ch&#7911;ng <i>Mycobacterium
tuberculosis </i>trong phòng thí nghi&#7879;m và trên lâm sàng. Các ch&#7911;ng
<i>Mycobacterium turbeculosis </i>lúc &#273;&#7847;u nh&#7841;y c&#7843;m v&#7899;i
thu&#7889;c, kháng thu&#7889;c r&#7845;t nhanh khi s&#7917; d&#7909;ng
&#273;&#417;n &#273;&#7897;c cycloserin trong &#273;i&#7873;u tr&#7883;. K&#7871;t
h&#7907;p cycloserin v&#7899;i các thu&#7889;c ch&#7889;ng lao khác, có th&#7875;
gi&#7843;m và phòng tránh &#273;&#432;&#7907;c s&#7921; kháng thu&#7889;c.
Cycloserin khi ph&#7889;i h&#7907;p v&#7899;i các thu&#7889;c hàng &#273;&#7847;u
ch&#7889;ng lao khác (streptomycin, isoniazid, rifampicin, ethambutol,
pyrazynamid) &#273;ã có tác d&#7909;ng trong &#273;i&#7873;u tr&#7883; lao
kháng thu&#7889;c. Vì tình hình kháng thu&#7889;c &#273;ang lan r&#7897;ng trên
th&#7871; gi&#7899;i nên c&#7847;n ph&#7843;i dùng h&#7841;n ch&#7871;
cycloserin, ch&#7881; dành cycloserin &#273;&#7875; &#273;i&#7873;u tr&#7883;
nh&#7919;ng ng&#432;&#7901;i b&#7879;nh &#273;ã m&#7855;c lao kháng thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Hi&#7879;n nay (5/2000), theo Ch&#432;&#417;ng
trình Ch&#7889;ng lao Vi&#7879;t Nam, cycloserin ch&#432;a &#273;&#432;&#7907;c
s&#7917; d&#7909;ng &#7903; Vi&#7879;t Nam vì các thu&#7889;c ch&#7889;ng lao
hàng &#273;&#7847;u còn hi&#7879;u qu&#7843;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Sau khi u&#7889;ng, 70% &#273;&#7871;n 90%
cycloserin &#273;&#432;&#7907;c h&#7845;p thu nhanh chóng. N&#7891;ng &#273;&#7897;
&#273;&#7881;nh trong máu &#273;&#7841;t &#273;&#432;&#7907;c sau 3 - 4 gi&#7901;
khi u&#7889;ng li&#7873;u 250 mg và có n&#7891;ng &#273;&#7897; t&#7915; 20 -
30 microgam/ml khi u&#7889;ng l&#7863;p l&#7841;i li&#7873;u cách nhau 12 gi&#7901;.
Ch&#7881; m&#7897;t l&#432;&#7907;ng nh&#7887; thu&#7889;c &#273;&#432;&#7907;c
tìm th&#7845;y sau 12 gi&#7901;. Cycloserin phân b&#7889; vào h&#7847;u h&#7871;t
các d&#7883;ch trong c&#417; th&#7875; và trong t&#7871; bào. N&#7891;ng &#273;&#7897;
thu&#7889;c trong d&#7883;ch não t&#7911;y, &#7903; ph&#7847;n l&#7899;n
ng&#432;&#7901;i b&#7879;nh, x&#7845;p x&#7881; n&#7891;ng &#273;&#7897; thu&#7889;c
trong máu. Kho&#7843;ng 50% l&#432;&#7907;ng thu&#7889;c h&#7845;p thu
&#273;&#432;&#7907;c th&#7843;i tr&#7915; vào n&#432;&#7899;c ti&#7875;u &#7903;
d&#7841;ng không &#273;&#7893;i trong 12 gi&#7901; &#273;&#7847;u, trong
&#273;ó 65% l&#432;&#7907;ng thu&#7889;c th&#7843;i tr&#7915; &#273;&#432;&#7907;c
tái h&#7845;p thu &#7903; d&#7841;ng có ho&#7841;t tính sau kho&#7843;ng
h&#417;n 72 gi&#7901;. Thu&#7889;c r&#7845;t ít &#273;&#432;&#7907;c chuy&#7875;n
hóa. Cycloserin có th&#7875; b&#7883; tích l&#361;y &#273;&#7871;n n&#7891;ng
&#273;&#7897; &#273;&#7897;c &#7903; ng&#432;&#7901;i b&#7879;nh suy th&#7853;n;
có th&#7875; lo&#7841;i thu&#7889;c ra kh&#7887;i c&#417; th&#7875; b&#7857;ng
th&#7849;m phân máu. Cycloserin d&#7877; qua nhau thai vào màng &#7889;i và vào
s&#7919;a m&#7865;. Thu&#7889;c không g&#7855;n v&#7899;i protein huy&#7871;t
t&#432;&#417;ng.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>B&#7879;nh lao kháng thu&#7889;c (dùng k&#7871;t h&#7907;p
v&#7899;i các thu&#7889;c ch&#7889;ng lao khác).<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Quá m&#7851;n v&#7899;i cycloserin, &#273;&#7897;ng
kinh, tr&#7847;m c&#7843;m, lo âu n&#7863;ng, lo&#7841;n tâm th&#7847;n, suy th&#7853;n
n&#7863;ng, nghi&#7879;n r&#432;&#7907;u.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>C&#7847;n l&#432;u ý khi ng&#432;&#7901;i b&#7879;nh
dùng quá 500 mg cycloserin/ngày. C&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u
sao cho n&#7891;ng &#273;&#7897; thu&#7889;c trong máu luôn d&#432;&#7899;i 30
microgam/ml, ng&#7897; &#273;&#7897;c cycloserin liên quan ch&#7863;t ch&#7869;
t&#7899;i n&#7891;ng &#273;&#7897; thu&#7889;c quá nhi&#7873;u trong máu (trên
30 microgam/ml).<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7901;i k&#7923; mang thai <o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ch&#7881; dùng khi th&#7853;t c&#7847;n thi&#7871;t.
<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Do ti&#7873;m n&#259;ng tác d&#7909;ng không mong
mu&#7889;n c&#7911;a cycloserin &#7903; tr&#7867; &#273;ang bú m&#7865;, vì v&#7853;y
nên cho tr&#7867; ng&#7915;ng bú khi ng&#432;&#7901;i m&#7865; c&#7847;n thi&#7871;t
ph&#7843;i dùng cycloserin.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n (ADR)<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Các tác d&#7909;ng không mong mu&#7889;n th&#432;&#7901;ng
g&#7863;p nh&#7845;t thu&#7897;c h&#7879; th&#7847;n kinh trung &#432;&#417;ng,
th&#432;&#7901;ng xu&#7845;t hi&#7879;n nhi&#7873;u vào 2 tu&#7847;n &#273;&#7847;u
&#273;i&#7873;u tr&#7883; và m&#7845;t &#273;i khi ng&#7915;ng thu&#7889;c. Các
bi&#7875;u hi&#7879;n th&#432;&#7901;ng th&#7845;y là ng&#7911; gà, &#273;au
&#273;&#7847;u, run r&#7849;y, lo&#7841;n v&#7853;n ngôn, chóng m&#7863;t, lú l&#7851;n,
h&#7889;t ho&#7843;ng, kích thích, tr&#7841;ng thái tâm th&#7847;n, có ý &#273;&#7883;nh
t&#7921; t&#7917;, hoang t&#432;&#7903;ng, ph&#7843;n &#7913;ng gi&#7843;m
tr&#432;&#417;ng l&#7921;c, co gi&#7853;t c&#417;, rung gi&#7853;t c&#7893;
chân, t&#259;ng ph&#7843;n x&#7841;, lo&#7841;n th&#7883;, li&#7879;t nh&#7865;,
c&#417;n co c&#7913;ng gi&#7853;t rung ho&#7863;c v&#7855;ng ý th&#7913;c. Dùng
li&#7873;u cao cycloserin ho&#7863;c u&#7889;ng r&#432;&#7907;u trong khi
&#273;i&#7873;u tr&#7883; s&#7869; làm t&#259;ng nguy c&#417; co gi&#7853;t. R&#7845;t
hi&#7871;m g&#7863;p viêm gan.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Ðau &#273;&#7847;u,
hoa m&#7855;t, lo âu, chóng m&#7863;t, ng&#7911; gà, run r&#7849;y, co gi&#7853;t,
tr&#7847;m c&#7843;m.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Thay &#273;&#7893;i
tâm th&#7847;n, thay &#273;&#7893;i nhân cách, kích thích, hung d&#7919;.<o:p></o:p></span></p>

<h3 align=left style='text-align:left;line-height:150%'><span lang=DE
style='font-size:9.0pt;line-height:150%;font-family:Verdana;mso-ansi-language:
DE'>Hi&#7871;m g&#7863;p, ADR &lt;1/1000<o:p></o:p></span></h3>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Da: Ban &#273;&#7887;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Máu: Thi&#7871;u máu
nguyên h&#7891;ng c&#7847;u kh&#7893;ng l&#7891;, thi&#7871;u máu nguyên h&#7891;ng
c&#7847;u nhi&#7877;m s&#7855;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Chuy&#7875;n hóa: Gi&#7843;m
h&#7845;p thu calci, magnesi; gi&#7843;m t&#7893;ng h&#7907;p protein.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Tác d&#7909;ng khác:
Thi&#7871;u vitamin B<sub>12</sub>, thi&#7871;u acid folic, lo&#7841;n nh&#7883;p
tim.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>H&#432;&#7899;ng d&#7851;n
cách x&#7917; trí ADR<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Các tác d&#7909;ng
không mong mu&#7889;n &#7843;nh h&#432;&#7903;ng &#273;&#7871;n h&#7879; th&#7847;n
kinh trung &#432;&#417;ng s&#7869; &#273;&#432;&#7907;c gi&#7843;m nh&#7865; n&#7871;u
n&#7891;ng &#273;&#7897; thu&#7889;c trong máu không quá 30 microgam/ml. N&#7871;u
có các tri&#7879;u ch&#7913;ng ng&#7897; &#273;&#7897;c th&#7847;n kinh c&#7847;n
gi&#7843;m li&#7873;u ho&#7863;c ng&#7915;ng thu&#7889;c. Có th&#7875; gi&#7843;m
nh&#7865; ho&#7863;c phòng tránh m&#7897;t s&#7889; tác d&#7909;ng ng&#7897;
&#273;&#7897;c th&#7847;n kinh b&#7857;ng cách dùng k&#7871;t h&#7907;p v&#7899;i
100 - 300 mg pyridoxin hydroclorid hàng ngày, chia nh&#7887; li&#7873;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Dùng các thu&#7889;c
ch&#7889;ng co gi&#7853;t và an th&#7847;n &#273;&#7875; gi&#7843;m co gi&#7853;t
và tr&#7841;ng thái lo l&#7855;ng, run r&#7849;y. <o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Li&#7873;u l&#432;&#7907;ng
và cách dùng<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Dùng theo &#273;&#432;&#7901;ng
u&#7889;ng, k&#7871;t h&#7907;p v&#7899;i các thu&#7889;c ch&#7889;ng lao khác
&#273;&#7875; &#273;i&#7873;u tr&#7883; lao.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Ng&#432;&#7901;i l&#7899;n:
B&#7855;t &#273;&#7847;u 250 mg/l&#7847;n, 12 gi&#7901; m&#7897;t l&#7847;n,
trong 2 tu&#7847;n &#273;&#7847;u sau &#273;ó th&#7853;n tr&#7885;ng t&#259;ng
li&#7873;u, n&#7871;u c&#7847;n, theo n&#7891;ng &#273;&#7897; thu&#7889;c
trong máu &#273;&#7871;n khi có &#273;áp &#7913;ng, cho &#273;&#7871;n t&#7889;i
&#273;a 500 mg m&#7895;i 12 gi&#7901; (li&#7873;u hàng ngày cao nh&#7845;t 15 -
20 mg/kg).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Tr&#7867; em: B&#7855;t
&#273;&#7847;u 10 mg/kg th&#7875; tr&#7885;ng m&#7897;t ngày và &#273;i&#7873;u
ch&#7881;nh li&#7873;u theo n&#7891;ng &#273;&#7897; thu&#7889;c trong máu và
&#273;áp &#7913;ng c&#7911;a thu&#7889;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Chú ý: </span></i><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Ph&#7843;i theo dõi n&#7891;ng
&#273;&#7897; thu&#7889;c trong máu, &#273;&#7863;c bi&#7879;t &#273;&#7889;i v&#7899;i
ng&#432;&#7901;i suy th&#7853;n ho&#7863;c khi dùng li&#7873;u v&#432;&#7907;t
quá 500 mg/ngày ho&#7863;c có d&#7845;u hi&#7879;u ng&#7897; &#273;&#7897;c. N&#7891;ng
&#273;&#7897; thu&#7889;c trong máu không &#273;&#432;&#7907;c v&#432;&#7907;t
quá 30 <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>microgam/ml. Ng&#432;&#7901;i
b&#7879;nh suy th&#7853;n (&#273;&#7897; thanh th&#7843;i creatinin &lt; 50
ml/phút {0,83 ml/giây}) không nên s&#7917; d&#7909;ng cycloserin do t&#259;ng
nguy c&#417; ng&#7897; &#273;&#7897;c th&#7847;n kinh.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>T&#432;&#417;ng tác
thu&#7889;c<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Cycloserin làm
t&#259;ng tác d&#7909;ng c&#7911;a r&#432;&#7907;u và phenytoin. Tác d&#7909;ng
không mong mu&#7889;n c&#7911;a cycloserin &#273;&#7889;i v&#7899;i h&#7879; th&#7847;n
kinh trung &#432;&#417;ng t&#259;ng lên khi dùng ph&#7889;i h&#7907;p v&#7899;i
isoniazid và ethionamid.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Cycloserin có tính
&#273;&#7889;i kháng v&#7899;i pyridoxin và làm t&#259;ng th&#7843;i tr&#7915;
pyridoxin &#7903; th&#7853;n; nhu c&#7847;u v&#7873; pyridoxin có th&#7875;
t&#259;ng &#7903; ng&#432;&#7901;i b&#7879;nh dùng cycloserin.<o:p></o:p></span></p>

<p class=normal1 align=left style='margin-top:0in;text-align:left;line-height:
150%'><span lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Ð&#7897; &#7893;n
&#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>B&#7843;o qu&#7843;n
nang cycloserin trong bao bì kín &#7903; nhi&#7879;t &#273;&#7897; d&#432;&#7899;i
40<sup>o</sup>C, t&#7889;t nh&#7845;t &#7903; 15 - 30<sup>o</sup>C. Cycloserin
b&#7873;n v&#7919;ng trong môi tr&#432;&#7901;ng ki&#7873;m nh&#432;ng b&#7883;
phân h&#7911;y nhanh trong môi tr&#432;&#7901;ng trung tính ho&#7863;c acid.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Quá li&#7873;u và x&#7917;
trí<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Tri&#7879;u ch&#7913;ng:
Ðau &#273;&#7847;u, chóng m&#7863;t, lú l&#7851;n, ng&#7911; gà, t&#259;ng kích
thích, d&#7883; c&#7843;m, lo&#7841;n v&#7853;n ngôn và tâm th&#7847;n. Li&#7879;t
nh&#7865;, co gi&#7853;t, và hôn mê có th&#7875; x&#7843;y ra khi dùng quá li&#7873;u
cycloserin nhi&#7873;u.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Ði&#7873;u tr&#7883;:
Gây nôn và/ho&#7863;c r&#7917;a d&#7841; dày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Dùng than ho&#7841;t
và thu&#7889;c x&#7893; 4 gi&#7901; m&#7897;t l&#7847;n cho &#273;&#7871;n khi
tình tr&#7841;ng &#7893;n &#273;&#7883;nh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Ði&#7873;u tr&#7883; h&#7895;
tr&#7907;. <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Dùng thu&#7889;c ch&#7889;ng
co gi&#7853;t &#273;&#7875; ki&#7875;m soát co gi&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Dùng 200 - 300 mg
pyridoxin hydroclorid hàng ngày chia nhi&#7873;u l&#7847;n &#273;&#7875;
&#273;i&#7873;u tr&#7883; ng&#7897; &#273;&#7897;c th&#7847;n kinh. <o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Thông tin qui ch&#7871;<o:p></o:p></span></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
lang=DE style='font-family:Verdana;mso-ansi-language:DE'>Thu&#7889;c &#273;&#7897;c
b&#7843;ng B.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Cycloserin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:49 GMT -->
</html>
